Trump’s Federal Workforce Plan Sparks Backlash in Austin President Donald Trump’s directive requiring all federal employees to return to the office five days a week has ignited fierce opposition from Austin-area elected officials. In response to anticipated resistance and the potential resignation of up to 10% of workers by September, the administration has introduced … Read more
n# RFK Jr.’s Confirmation Hearing: A Struggle to Address Key Health Policy Questions In a contentious confirmation hearing to become the nation’s top health official, Robert F. Kennedy Jr. faced intense scrutiny over his plans for reforming Medicaid and Medicare, two critical government health care programs that serve millions of disabled, poor, and older Americans. … Read more
The Shkreli Awards, an annual event hosted by the Lown Institute, have become a biting critique of the American healthcare system. Named after the infamous “pharma bro” Martin shkreli, these awards spotlight the most egregious examples of profiteering and dysfunction in healthcare.This year’s ceremony, the eighth edition, continued to shine a light on the systemic … Read more
The majority of Americans believe that prescription drug costs are unreasonable, with many pointing to pharmaceutical company profits as a key driver of these high prices, according to a survey by KFF. While 65% of adults report that paying for prescriptions is manageable, those taking four or more medications face greater challenges. As … Read more
Biden Management Pushes Forward with Prescription Drug Affordability Efforts in Final Days as President Joe Biden prepares to transition power to Donald Trump, his administration is making a final push to address one of its most significant yet underappreciated achievements: lowering the cost of prescription drugs. On Friday morning, the Department of Health and … Read more
The Centers for Medicare & Medicaid Services (CMS) has announced the selection of 15 additional drugs for its second round of price negotiations,a move that could substantially impact the cost of medications for millions of Americans. Among the drugs chosen are the widely popular weight loss medications Ozempic and Wegovy, which have seen a … Read more
Medicare’s $2,000 Prescription Drug Cap: A Lifeline for Millions in 2025 For millions of older Americans,the new $2,000 cap on out-of-pocket prescription drug costs under Medicare Part D is more than just a policy change—it’s a financial lifeline. According to a report released by AARP, this cap, which took effect at the start of 2025, … Read more
West Virginia Health Advocates Join National Outcry Against RFK Jr.’s HHS Nomination Health care advocates in West Virginia have joined a growing chorus of physicians and public health professionals across the nation urging the U.S.Senate to reject President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. as head of the Department of Health and human … Read more
Medicare Part D Drug Prices Nearly double Since Market Entry, AARP Report Finds Table of Contents Medicare Part D Drug Prices Nearly double Since Market Entry, AARP Report Finds Medicare’s New Power to Negotiate Drug Prices key Findings from the AARP Report New Protections for Medicare Beneficiaries The Human Cost of … Read more
Medicare Coverage for Zepbound: what you Need too Know Table of Contents Medicare Coverage for Zepbound: what you Need too Know What is Zepbound? Medicare Coverage for Zepbound: The New Rules Key Points to Remember: How Does Zepbound Compare to Other Weight Loss Drugs? What This Means for Medicare Beneficiaries Final Thoughts … Read more